Molly Ryan is named as a lobbyist on federal disclosure filings for 2 clients through Otsuka America Pharmaceutical, Inc. and 1 other registrant. The most recent filing naming them posted in July 2022. Issues reported include Health Issues and Medicare/Medicaid.
Medical/Disease Research/Clinical Labs, Science/Technology, Alcohol and Drug Abuse
Activity by year
Year
Clients
Registrants
2022
1
1
2021
1
1
2020
1
1
Contributions reported on Form LD-203
Year
Items
Total
2022
3
$1K
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Molly Ryan. See the Capitol Clarity rankings and method.